Misoprostol: Nursing Drug Guide, Pregnancy Risk & Hold Rules

Misoprostol is the generic prostaglandin E1 analog; nurses most often see it as Cytotec 100 mcg or 200 mcg oral tablets. It also appears in the fixed combination Arthrotec (diclofenac/misoprostol)—reconcile so misoprostol is not duplicated.

Cytotec tablets are hexagonal white 100 mcg or 200 mcg strengths. Arthrotec pairs diclofenac with misoprostol for rheumatoid arthritis or osteoarthritis patients at high GI risk. When the MAR lists both Arthrotec and separate Cytotec, stop and clarify with pharmacy before administration.

Cytotec is indicated to reduce the risk of NSAID-induced gastric ulcers in patients at high risk of ulcer complications (for example older adults, debilitated patients, or those with ulcer history) while taking NSAIDs including aspirin, ibuprofen, celecoxib, or diclofenac. It has not been shown to reduce duodenal ulcer risk and does not treat NSAID-related GI pain per labeling.

↔On a small screen, swipe or scroll sideways to see the full table.

Misoprostol is a synthetic prostaglandin E1 analog that inhibits gastric acid secretion and increases bicarbonate and mucus production at antisecretory doses (200 mcg and above). NSAIDs deplete gastric prostaglandins; misoprostol replaces mucosal protection while the NSAID continues. It also produces uterine contractions that can endanger pregnancy—nurses connect pharmacology to the boxed warning, not only to GI prophylaxis.

The recommended adult dose for NSAID ulcer prophylaxis is 200 mcg four times daily with food. If not tolerated, 100 mcg four times daily may be used. Continue for the full NSAID course as prescribed.

Missed dose: Not specified in the reviewed prescribing information. If a dose is missed, do not double without prescriber or pharmacist guidance—NSAID ulcer protection depends on continued QID therapy.

↔On a small screen, swipe or scroll sideways to see the full table.

Pretreatment checks

• Complete medication reconciliation: confirm concurrent NSAID, exclude duplicate misoprostol from Arthrotec or other sources, verify 100 vs 200 mcg strength
• Women of childbearing potential: negative serum pregnancy test within 2 weeks, effective contraception documented, therapy started day 2–3 of menses when applicable, oral and written abortifacient warnings given
• Confirm not pregnant; no prostaglandin allergy; assess baseline stool pattern and hydration for diarrhea monitoring

Contraindications

• Pregnancy when used to reduce NSAID-induced ulcers (Category X)
• History of allergy to prostaglandins
• Use in pregnant women for NSAID ulcer prophylaxis—see boxed warnings

Important interactions

↔On a small screen, swipe or scroll sideways to see the full table.

Route: Oral tablet (100 or 200 mcg) swallowed with a meal; the last daily dose should be at bedtime per labeling.

• Give with food to minimize diarrhea; avoid skipping the bedtime dose
• Confirm tablet strength (100 vs 200 mcg) and QID schedule—not PRN
• Ensure NSAID dose is taken as ordered; misoprostol does not replace NSAID pain dosing

• Reduced endoscopic gastric ulcer rates in NSAID users at 200 mcg QID in 12-week trials—clinical pain relief may be unchanged
• Early diarrhea or cramping may occur during the first 1–2 weeks and often self-limits per labeling
• No effect on NSAID efficacy for rheumatoid arthritis signs/symptoms in aspirin combination trials

Stop therapy and escalate per protocol when pregnancy, severe GI losses, or hypersensitivity appear—misoprostol errors can harm two patients when tablets are shared.

• Positive or suspected pregnancy—discontinue immediately; Category X abortifacient risk
• Severe or prolonged diarrhea with dehydration, especially in inflammatory bowel disease or fragile patients
• Vaginal bleeding, cramping, or passage of tissue—possible abortion; urgent evaluation
• Anaphylaxis or severe rash after dose—discontinue prostaglandin therapy
• Patient reports sharing tablets or taking borrowed Cytotec—medication safety incident requiring prescriber/pharmacy notification

Cytotec labeling reports dose-related GI effects most often during the first weeks of therapy. Nurses distinguish expected early diarrhea from dehydration, pregnancy-related bleeding, or hypersensitivity.

↔On a small screen, swipe or scroll sideways to see the full table.

The toxic dose in humans has not been determined. Cytotec labeling states cumulative total daily doses of 1600 mcg have been tolerated with only GI discomfort reported.

Management

• No specific antidote is known—provide supportive therapy for sedation, tremor, convulsions, dyspnea, abdominal pain, diarrhea, fever, palpitations, hypotension, or bradycardia per labeling
• Discontinue misoprostol; monitor hydration, vitals, and uterine effects if pregnancy possible
• Contact local poison control or medical toxicology services per facility protocol when ingestion is intentional or symptoms are severe
• Dialysis is unlikely to be useful because misoprostol is metabolized like a fatty acid

• Cytotec vs other “-tec/-tol” agents—read full generic name misoprostol on MAR and blister pack
• 200 mcg vs 100 mcg tablets—independent double-check strength before administration
• Arthrotec (diclofenac/misoprostol)—do not duplicate misoprostol when combination product is already ordered
• Shared tablets—labeling warns patients must not give Cytotec to others; treat borrowed/shared doses as serious medication errors
• Obstetric off-label use—outside ulcer prophylaxis indication, uterine rupture and fetal harm risks differ; follow prescriber orders and facility policy only

↔On a small screen, swipe or scroll sideways to see the full table.

↔On a small screen, swipe or scroll sideways to see the full table.

Monitor

• Stool frequency, cramping, hydration, and weight during first weeks of therapy
• Pregnancy prevention adherence and menstrual history in women of childbearing potential
• Vaginal bleeding or spotting—distinguish expected spotting rates from abnormal bleeding needing workup

Document

• Pregnancy test date, contraception method, and abortifacient warnings in chart
• NSAID name/dose on MAR alongside each misoprostol dose
• Diarrhea severity, hold events, and medication-sharing incidents

• Take every dose with food; last dose at bedtime; do not stop because of mild early diarrhea without prescriber advice
• Never share Cytotec— it can cause miscarriage or birth defects in a pregnant woman
• Use effective contraception; tell your clinician immediately if pregnancy is possible or menses is late
• Report severe abdominal pain, heavy bleeding, or diarrhea lasting more than about a week
• Keep tablets out of reach of children and away from other women who could become pregnant

Do not give and contact the prescriber/pharmacist when:

Hold parameters may vary by institutional protocol. Follow prescriber orders, pharmacy guidance, and facility policy.

Practice NCLEX-style clinical judgment practice for misoprostol using a tabbed case (MAR · Labs · History · Nursing notes) about a woman of childbearing potential on misoprostol plus ibuprofen, then work through priority action, SATA cue recognition, trend SATA, matrix urgency sorting, medication-sharing judgment, and a documentation cloze—recognise cues → analyse → prioritise → act → evaluate outcomes.

Unfolding case. Elena is a 32-year-old woman with rheumatoid arthritis on ibuprofen 600 mg PO TID plus misoprostol 200 mcg PO QID with meals for NSAID ulcer prophylaxis. She is of childbearing potential. Her last serum pregnancy test was 10 days ago (negative). Today she reports four loose stools, asks to skip misoprostol because of cramping, and mentions giving leftover Cytotec to her sister. Review the case tabs before the 1200 doses.

This medication guide is written and reviewed using NurseOnShift editorial and clinical review standards.

• Editorial Policy
• Medical Review Process
• Disclaimer

Educational use only. This content does not replace clinical judgment, prescriber orders, pharmacist guidance, product labeling, or institutional protocols.